Adjuvants for Immunotherapy and Vaccine Development
Whether you specialize in lipidomics, or lipids are a regular part of your research, you will know the critical role they play. For example, adjuvants using heterogeneous monophosphoryl Lipid A (MPL) derived from Salmonella minnesota R595, have proven to be safe and effective at inducing Th-1 type immune responses to heterologous proteins in animal and human vaccines. While adjuvant systems play a key part in immunotherapy and vaccine development programs, adjuvant formulation can be a costly and time-consuming process. Partnering with a company with expertise in lipid formulation can help to relieve this burden.
Download this flyer to discover:
- Various monophosphoryl lipid A (MPLA) adjuvants
- A trehalose dibehenate and DDA adjuvant system for tuberculosis vaccines
